No. Title Date 16 GI Innovation signed a contract with Medirama for joint research development of next generation innovative immuno-oncology 2021-12-08 15 GI Innovation sings MoU for a new biopharmaceutical development with Merck 2021-11-22 14 GI Innovation released passing of early clinical research of GI-101 in SITC, U.S.A 2021-11-15 13 GI Innovation passes the evaluation stage for Unicorn fast track IPO and acquires the domestic patent for next generation immuno-oncology 2021-11-04 12 GI Innovation signs MoU for immuno-oncology co-development with Medirama 2021-09-29 11 GI buckles down to global clinical trials for immuno-oncology after approval of U.S. IND and finished pre-IPO from SK Holding company, NH Investment & Securities, which reached up to 160 billion won 2021-06-15 10 GI Innovation, recruited Chief Operating Officer Hong Jun Ho, former CEO of Interpark bio convergence corp.…200billion strategic investment was attracted from iMarketKorea, subsidiary of interpark 2021-04-05 9 GI Innovation, Starting of KOSDAQ listing...Getting A, A, A level in technology evaluation of the three specialized evaluation agencies 2021-02-08 8 GI innovation and Lunit sign MOU joint research for the next generation new innovative drug development 2021-01-20 7 GI - Severance Hospital, signs MOU on joint research for new innovative drug development 2021-01-05 Title Content < 1 2 3 4 >
